BLIS Technology forecasts wider 2013 loss, seeks to raise capital

BLIS Technology forecasts wider 2013 loss, seeks to raise capital
By Hannah Lynch Aug 31 (BusinessDesk) - BLIS Technologies, the NZX-listed biotechnology company, widened its forecast 2013 loss and launched a share purchase plan and placement in a bid to raise up to $1.5 million. The Dunedin-based company said its operating loss in the year ending March 31 may be $1.3 million, up from the loss of $800,000 million it affirmed in July. The change reflects BLIS's decision to suspend the promotion and sales of its patented K12 probiotic in the US and China and M18 in the US. It is also undertaking a review of...